| Gene symbol | IL10 | Synonyms | CSIF, GVHDS, IL-10, IL10A, TGIF | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q32.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | interleukin 10 | ||||
| GTO ID | GTC2655 |
| Trial ID | NCT04841512 |
| Disease | Osteoarthritis |
| Altered gene | IL-10 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | XT-150 |
| Phase | Phase1|Phase2 |
| Recruitment status | Withdrawn |
| Title | A Placebo-controlled, Double-blind Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Facet Joint Osteoarthritis Pain |
| Year | 2021 |
| Country | Australia |
| Company sponsor | Xalud Therapeutics, Inc. |
| Other ID(s) | XT-150-1-0301 |
| Vector information | |||
|
|||
| Cohort 1 | |||||
|
|||||